Skip to main content


Page 4 of 7

  1. It is now recognized that TSH can act on targets other than the thyroid, including the liver. Elevated serum TSH levels in euthyroid subjects were recently reported to correlate with high values of serum propr...

    Authors: AnneMarie Gagnon, Moeber Mahzari, Heather A Lochnan and Alexander Sorisky
    Citation: Thyroid Research 2014 7:4
  2. Thyroid metastases account for approximately 1.4-3% of all malignancies of the thyroid gland. Thyroid metastases are most common in: clarocellular carcinoma of the kidney, lung cancer, breast cancer, malignant...

    Authors: Monika Koziołek, Anna Sieradzka, Lilianna Osowicz-Korolonek, Ewa Wentland-Kotwicka, Katarzyna Karpińska-Kaczmarczyk and Anhelli Syrenicz
    Citation: Thyroid Research 2014 7:1
  3. Studies based on laboratory data about thyroid stimulating hormone (TSH) and free thyroxine (FT4) reference interval (RI) show conflicting results regarding the importance of using specific values by age group...

    Authors: Rosita Fontes, Claudia Regina Coeli, Fernanda Aguiar and Mario Vaisman
    Citation: Thyroid Research 2013 6:13
  4. Serum concentration of soluble interleukin-2 receptor (sIL-2R) has been established as a reliable marker of T-lymphocyte activation. However, there have been no reports describing the relationship between seru...

    Authors: Kae Hamamoto, Masaaki Inaba, Shinsuke Yamada, Maki Yoda, Koichiro Yoda, Hitoshi Goto, Masafumi Kurajoh and Hidenori Koyama
    Citation: Thyroid Research 2013 6:12
  5. Thyrotoxicosis is a cause of secondary osteoporosis. High concentrations of triiodotironine (T3) in Graves’ disease stimulate bone turnover, but it is unclear if euthyroidism will always normalize bone metabol...

    Authors: Monica A Ercolano, Monica L Drnovsek, Maria C Silva Croome, Monica Moos, Ana M Fuentes, Fanny Viale, Ulla Feldt-Rasmussen and Alicia T Gauna
    Citation: Thyroid Research 2013 6:11
  6. Fenton reaction (Fe2++H2O2→Fe3++OH+OH) is of special significance in the thyroid gland, as both its substrates, i.e. H2O2 and Fe2+, are required for thyroid hormone synthesis. Also iodine, an essential element ...

    Authors: Magdalena Milczarek, Jan Stępniak, Andrzej Lewiński and Małgorzata Karbownik-Lewińska
    Citation: Thyroid Research 2013 6:10
  7. In order to assess safety of radioactive iodine administration in the treatment of thyrotoxicosis, we measured concentrations of matrix metalloproteinase-2 (MMP-2), its main inhibitor – TIMP-2 (tissue inhibito...

    Authors: Andrzej Lewinski, Anna Brona, Krzysztof C Lewandowski, Diana Jedrzejuk, Anna Bohdanowicz-Pawlak, Elżbieta Skowronska-Jozwiak, Małgorzata Bienkiewicz and Andrzej Milewicz
    Citation: Thyroid Research 2013 6:9
  8. Associations between breast cancer and thyroid disorders are reported in numerous studies. Relationships between thyroperoxidase antibodies (TPOAb), thyroglobulin antibodies (TgAb) and breast cancer have been ...

    Authors: Paweł Szychta, Wojciech Szychta, Adam Gesing, Andrzej Lewiński and Małgorzata Karbownik-Lewińska
    Citation: Thyroid Research 2013 6:8
  9. Hyperfunctioning nodules of the thyroid are thought to only rarely harbor thyroid cancer, and thus are infrequently biopsied. Here, we present the case of a patient with a hyperfunctioning thyroid nodule harbo...

    Authors: Sasan Mirfakhraee, Dana Mathews, Lan Peng, Stacey Woodruff and Jeffrey M Zigman
    Citation: Thyroid Research 2013 6:7
  10. The standard management in patients with thyroid nodules is to assess the risk of malignancy, based on cytological examination. On the other hand, there are thyroid patterns of ultrasound (US) image, associate...

    Authors: Zbigniew Adamczewski and Andrzej Lewiński
    Citation: Thyroid Research 2013 6:6
  11. Authors: Jacek Sygut, Aldona Kowalska, Janusz Słuszniak, Jacek Heciak, Janusz Kopczyński, Dominik Sygut, Kornelia Niemyska and Stanisław Góźdź
    Citation: Thyroid Research 2013 6(Suppl 2):A59

    This article is part of a Supplement: Volume 6 Supplement 2

  12. Authors: Magdalena Rudzińska, Damian Gaweł, Anna Stachurska, Hanna Domek, Jolanta Czerwińska, Mirosław Kiedrowski, Tomasz Stępień, Dariusz Lange and Barbara Czarnocka
    Citation: Thyroid Research 2013 6(Suppl 2):A51

    This article is part of a Supplement: Volume 6 Supplement 2

  13. Authors: Aleksandra Król, Jolanta Krajewska, Barbara Michalik, Ewa Paliczka-Cieślik, Michał Kalemba, Beata Jurecka-Lubieniecka, Kornelia Hasse-Lazar, Sylwia Szpak-Ulczok, Łukasz Zarudzki and Barbara Jarząb
    Citation: Thyroid Research 2013 6(Suppl 2):A34

    This article is part of a Supplement: Volume 6 Supplement 2

Annual Journal Metrics